Susan M. Lobo-Ruppert - Publications

Affiliations: 
University of Alabama, Birmingham, Birmingham, AL, United States 
Area:
Genetics, Molecular Biology

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Desphande A, Xia G, Boerma LJ, Vines KK, Atigadda VR, Lobo-Ruppert S, Grubbs CJ, Moeinpour FL, Smith CD, Christov K, Brouillette WJ, Muccio DD. Methyl-substituted conformationally constrained rexinoid agonists for the retinoid X receptors demonstrate improved efficacy for cancer therapy and prevention. Bioorganic & Medicinal Chemistry. 22: 178-85. PMID 24359708 DOI: 10.1016/J.Bmc.2013.11.039  0.324
2014 Boerma LJ, Xia G, Qui C, Cox BD, Chalmers MJ, Smith CD, Lobo-Ruppert S, Griffin PR, Muccio DD, Renfrow MB. Defining the communication between agonist and coactivator binding in the retinoid X receptor α ligand binding domain. The Journal of Biological Chemistry. 289: 814-26. PMID 24187139 DOI: 10.1074/Jbc.M113.476861  0.319
2009 Liu Z, Teng L, Bailey SK, Frost AR, Bland KI, LoBuglio AF, Ruppert JM, Lobo-Ruppert SM. Epithelial transformation by KLF4 requires Notch1 but not canonical Notch1 signaling. Cancer Biology & Therapy. 8: 1840-51. PMID 19717984 DOI: 10.4161/Cbt.8.19.9440  0.404
2009 Jiang W, Deng W, Bailey SK, Nail CD, Frost AR, Brouillette WJ, Muccio DD, Grubbs CJ, Ruppert JM, Lobo-Ruppert SM. Prevention of KLF4-mediated tumor initiation and malignant transformation by UAB30 rexinoid. Cancer Biology & Therapy. 8: 289-98. PMID 19197145 DOI: 10.4161/cbt.8.3.7486  0.34
2007 Li X, Deng W, Lobo-Ruppert SM, Ruppert JM. Gli1 acts through Snail and E-cadherin to promote nuclear signaling by β-catenin Oncogene. 26: 4489-4498. PMID 17297467 DOI: 10.1038/Sj.Onc.1210241  0.321
2006 Mukherjee S, Frolova N, Sadlonova A, Novak Z, Steg A, Page GP, Welch DR, Lobo-Ruppert SM, Ruppert JM, Johnson MR, Frost AR. Hedgehog signaling and response to cyclopamine differ in epithelial and stromal cells in benign breast and breast cancer. Cancer Biology & Therapy. 5: 674-83. PMID 16855373 DOI: 10.4161/Cbt.5.6.2906  0.381
2006 Li X, Deng W, Nail CD, Bailey SK, Kraus MH, Ruppert JM, Lobo-Ruppert SM. Snail induction is an early response to Gli1 that determines the efficiency of epithelial transformation Oncogene. 25: 609-621. PMID 16158046 DOI: 10.1038/Sj.Onc.1209077  0.432
2005 Huang CC, Liu Z, Li X, Bailey SK, Nail CD, Foster KW, Frost AR, Ruppert JM, Lobo-Ruppert SM. KLF4 and PCNA identify stages of tumor initiation in a conditional model of cutaneous squamous epithelial neoplasia. Cancer Biology & Therapy. 4: 1401-8. PMID 16357510 DOI: 10.4161/Cbt.4.12.2355  0.384
2005 Foster KW, Liu Z, Nail CD, Li X, Fitzgerald TJ, Bailey SK, Frost AR, Louro ID, Townes TM, Paterson AJ, Kudlow JE, Lobo-Ruppert SM, Ruppert JM. Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia. Oncogene. 24: 1491-500. PMID 15674344 DOI: 10.1038/Sj.Onc.1208307  0.345
2004 Pandya AY, Talley LI, Frost AR, Fitzgerald TJ, Trivedi V, Chakravarthy M, Chhieng DC, Grizzle WE, Engler JA, Krontiras H, Bland KI, LoBuglio AF, Lobo-Ruppert SM, Ruppert JM. Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 2709-19. PMID 15102675 DOI: 10.1158/1078-0432.Ccr-03-0484  0.329
2001 Zhou D, Lobo-Ruppert SM. Transcription of the Schizosaccharomyces pombe U2 gene in vivo and in vitro is directed by two essential promoter elements. Nucleic Acids Research. 29: 2003-11. PMID 11353068 DOI: 10.1093/Nar/29.10.2003  0.419
2000 McCulloch V, Hardin P, Peng W, Ruppert JM, Lobo-Ruppert SM. Alternatively spliced hBRF variants function at different RNA polymerase III promoters. The Embo Journal. 19: 4134-43. PMID 10921893 DOI: 10.1093/Emboj/19.15.4134  0.445
Show low-probability matches.